资讯
Rare earth elements sustain the Information Age, and securing a supply of these metals has become a matter of national and economic security. They’re ubiquitous in our smart technologies, high ...
Deferiprone is an iron chelator used for transfusion-dependent thalassemia at daily doses of 100 mg per kilogram of body weight and is able to cross the blood–brain barrier. 9-11 Deferiprone at ...
Ratio Therapeutics (PRNewsfoto/Ratio Therapeutics Inc.) Macropa is a proprietary, best-in-class, bifunctional chelator for Actinium-225 (Ac-225), known for its strong alpha-particle emissions and ...
(HealthDay)—A mitochondria-targeted iron chelator can protect primary skin fibroblasts against the harmful effects of ultraviolet A (UVA), according to a study published in the August issue of ...
In chelator treatments, barriers placed 30 cm deep reduced leaching of Pb, Zn and Cd by 435, 4 and 53 times, respectively, compared to columns with no barrier, where 3.0, 4.3 and 3.3% of total initial ...
Algeta has negotiated a 12-month option to license Lumiphore’s Lumi4® chelator technology for use in the development of therapeutic radiopharmaceuticals.
INDORE: Health authorities in Madhya Pradesh have directed all chief medical and health officers (CMHOs) for sending samples of all batches of an iron chelator drug (defrasirox tablets) to state ...
TEHRAN — An Iranian knowledge-based company succeed in manufacturing oral iron chelator, deferasirox, domestically, Mehr news agency reported. Deferasirox is an oral iron chelator. Its main use is to ...
State health authorities in Indore are investigating complaints of side-effects from an iron chelator drug. All batches of the drug are being tested at the state drug lab. Find out more.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果